BURROUGHS AMY L. (Chief Executive Officer) sold 19.2% of their position (68.75K shares) of TERNS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $2.55M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+150K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+27.08K
Price / share
$4.64
Trade value
$125.67K
% of position
Common Stock
Shares
+27.08K
Price / share
$4.64
Trade value
$125.67K
% of position
Common Stock
Shares
+14.58K
Price / share
$4.64
Trade value
$67.67K
% of position
Common Stock
Shares
−61.23K
Price / share
$37.02
Trade value
$2.27M
% of position
Common Stock
Shares
−7.52K
Price / share
$37.53
Trade value
$282.23K
% of position
Net shares
+150K
Net value
-$2.23M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/14/2026 | A · Award | +150K | — | — | 107.9% | 138.98K | 288.98K |
| Common Stock Direct | 1/15/2026 | M · Option Exercise | +27.08K | $4.64 | $125.67K | 9.4% | 288.98K | 316.06K |
| Common Stock Direct | 1/15/2026 | M · Option Exercise | +27.08K | $4.64 | $125.67K | 8.6% | 316.06K | 343.14K |
| Common Stock Direct | 1/15/2026 | M · Option Exercise | +14.58K | $4.64 | $67.67K | 4.2% | 343.14K | 357.73K |
| Common Stock Direct | 1/15/2026 | S · Sale | −61.23K | $37.02 | $2.27M | 17.1% | 357.73K | 296.50K |
| Common Stock Direct | 1/15/2026 | S · Sale | −7.52K | $37.53 | $282.23K | 2.5% | 296.50K | 288.98K |
| Total | +150K | -$2.23M | ||||||
Stock Option (Right to Buy)
Common Stock
300K shares
Shares
+300K
Strike price
37.18
Held after
300K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
27.08K shares
Shares
−27.08K
Strike price
4.64
Held after
1.03M
Exercisable
—
Stock Option (Right to Buy)
Common Stock
27.08K shares
Shares
−27.08K
Strike price
4.64
Held after
999.28K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
14.58K shares
Shares
−14.58K
Strike price
4.64
Held after
984.70K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock300K shares | 1/14/2026 | A · Award | +300K | 37.18 | — | 300K |
| Stock Option (Right to Buy) Direct | Common Stock27.08K shares | 1/15/2026 | M · Option Exercise | −27.08K | 4.64 | — | 1.03M |
| Stock Option (Right to Buy) Direct | Common Stock27.08K shares | 1/15/2026 | M · Option Exercise | −27.08K | 4.64 | — | 999.28K |
| Stock Option (Right to Buy) Direct | Common Stock14.58K shares | 1/15/2026 | M · Option Exercise | −14.58K | 4.64 | — | 984.70K |
Common Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 8.32K | Indirect |
| Total | 8.32K | 8.32K indirect |